Bile duct proliferation in Jag1/fringe heterozygous mice identifies candidate modifiers of the Alagille syndrome hepatic phenotype

Matthew J. Ryan, Christina Bales, Anthony Nelson, Dorian M. Gonzalez, Lara Underkoffler, Michelle Segalov, Norma Wilson-Rawls, Susan E. Cole, Jennifer L. Moran, Pierre Russo, Nancy B. Spinner, Kenro Kusumi, Kathleen M. Loomes

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Alagille syndrome (AGS) is a heterogeneous developmental disorder associated with bile duct paucity and various organ anomalies. The syndrome is caused by mutations in JAG1, which encodes a ligand in the Notch signaling pathway, in the majority of cases and mutations in the NOTCH2 receptor gene in less than 1% of patients. Although a wide array of JAG1 mutations have been identified in the AGS population, these mutational variants have not accounted for the wide phenotypic variability observed in patients with this syndrome. The Fringe genes encode glycosyltransferases, which modify Notch and alter ligand-receptor affinity. In this study, we analyzed double heterozygous mouse models to examine the Fringe genes as potential modifiers of the Notchmediated hepatic phenotype observed in AGS. We generated mice that were haploinsufficient for both Jag1 and one of three paralogous Fringe genes: Lunatic (Lfng), Radical (Rfng), and Manic (Mfng). Adult Jag1+/ - Lfng+/- and Jag1/-Rfng+/ mouse livers exhibited widespread bile duct proliferation beginning at 5 weeks of age and persisting up to 1 year. The Jag1+/-Mfng+/- livers showed a subtle, yet significant increase in bile duct numbers and bile duct to portal tract ratios. These abnormalities were not observed in the newborn period. Despite the portal tract expansion by bile ducts, fibrosis was not increased and epithelial to mesenchymal transition was not shown in the affected portal tracts. Conclusion: Mice heterozygous for mutations in Jag1 and the Fringe genes display striking bile duct proliferation, which is not apparent at birth. These findings suggest that the Fringe genes may regulate postnatal bile duct growth and remodeling, and serve as candidate modifiers of the hepatic phenotype in AGS.

Original languageEnglish (US)
Pages (from-to)1989-1997
Number of pages9
JournalHepatology
Volume48
Issue number6
DOIs
StatePublished - 2008

Fingerprint

Alagille Syndrome
Bile Ducts
Phenotype
Liver
Genes
Mutation
Ligands
Glycosyltransferases
Epithelial-Mesenchymal Transition
Fibrosis
Parturition
Newborn Infant

ASJC Scopus subject areas

  • Hepatology
  • Medicine(all)

Cite this

Ryan, M. J., Bales, C., Nelson, A., Gonzalez, D. M., Underkoffler, L., Segalov, M., ... Loomes, K. M. (2008). Bile duct proliferation in Jag1/fringe heterozygous mice identifies candidate modifiers of the Alagille syndrome hepatic phenotype. Hepatology, 48(6), 1989-1997. https://doi.org/10.1002/hep.22538

Bile duct proliferation in Jag1/fringe heterozygous mice identifies candidate modifiers of the Alagille syndrome hepatic phenotype. / Ryan, Matthew J.; Bales, Christina; Nelson, Anthony; Gonzalez, Dorian M.; Underkoffler, Lara; Segalov, Michelle; Wilson-Rawls, Norma; Cole, Susan E.; Moran, Jennifer L.; Russo, Pierre; Spinner, Nancy B.; Kusumi, Kenro; Loomes, Kathleen M.

In: Hepatology, Vol. 48, No. 6, 2008, p. 1989-1997.

Research output: Contribution to journalArticle

Ryan, MJ, Bales, C, Nelson, A, Gonzalez, DM, Underkoffler, L, Segalov, M, Wilson-Rawls, N, Cole, SE, Moran, JL, Russo, P, Spinner, NB, Kusumi, K & Loomes, KM 2008, 'Bile duct proliferation in Jag1/fringe heterozygous mice identifies candidate modifiers of the Alagille syndrome hepatic phenotype', Hepatology, vol. 48, no. 6, pp. 1989-1997. https://doi.org/10.1002/hep.22538
Ryan, Matthew J. ; Bales, Christina ; Nelson, Anthony ; Gonzalez, Dorian M. ; Underkoffler, Lara ; Segalov, Michelle ; Wilson-Rawls, Norma ; Cole, Susan E. ; Moran, Jennifer L. ; Russo, Pierre ; Spinner, Nancy B. ; Kusumi, Kenro ; Loomes, Kathleen M. / Bile duct proliferation in Jag1/fringe heterozygous mice identifies candidate modifiers of the Alagille syndrome hepatic phenotype. In: Hepatology. 2008 ; Vol. 48, No. 6. pp. 1989-1997.
@article{b755a1d9dcb04191a5184bc987fc8b44,
title = "Bile duct proliferation in Jag1/fringe heterozygous mice identifies candidate modifiers of the Alagille syndrome hepatic phenotype",
abstract = "Alagille syndrome (AGS) is a heterogeneous developmental disorder associated with bile duct paucity and various organ anomalies. The syndrome is caused by mutations in JAG1, which encodes a ligand in the Notch signaling pathway, in the majority of cases and mutations in the NOTCH2 receptor gene in less than 1{\%} of patients. Although a wide array of JAG1 mutations have been identified in the AGS population, these mutational variants have not accounted for the wide phenotypic variability observed in patients with this syndrome. The Fringe genes encode glycosyltransferases, which modify Notch and alter ligand-receptor affinity. In this study, we analyzed double heterozygous mouse models to examine the Fringe genes as potential modifiers of the Notchmediated hepatic phenotype observed in AGS. We generated mice that were haploinsufficient for both Jag1 and one of three paralogous Fringe genes: Lunatic (Lfng), Radical (Rfng), and Manic (Mfng). Adult Jag1+/ - Lfng+/- and Jag1/-Rfng+/ mouse livers exhibited widespread bile duct proliferation beginning at 5 weeks of age and persisting up to 1 year. The Jag1+/-Mfng+/- livers showed a subtle, yet significant increase in bile duct numbers and bile duct to portal tract ratios. These abnormalities were not observed in the newborn period. Despite the portal tract expansion by bile ducts, fibrosis was not increased and epithelial to mesenchymal transition was not shown in the affected portal tracts. Conclusion: Mice heterozygous for mutations in Jag1 and the Fringe genes display striking bile duct proliferation, which is not apparent at birth. These findings suggest that the Fringe genes may regulate postnatal bile duct growth and remodeling, and serve as candidate modifiers of the hepatic phenotype in AGS.",
author = "Ryan, {Matthew J.} and Christina Bales and Anthony Nelson and Gonzalez, {Dorian M.} and Lara Underkoffler and Michelle Segalov and Norma Wilson-Rawls and Cole, {Susan E.} and Moran, {Jennifer L.} and Pierre Russo and Spinner, {Nancy B.} and Kenro Kusumi and Loomes, {Kathleen M.}",
year = "2008",
doi = "10.1002/hep.22538",
language = "English (US)",
volume = "48",
pages = "1989--1997",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "6",

}

TY - JOUR

T1 - Bile duct proliferation in Jag1/fringe heterozygous mice identifies candidate modifiers of the Alagille syndrome hepatic phenotype

AU - Ryan, Matthew J.

AU - Bales, Christina

AU - Nelson, Anthony

AU - Gonzalez, Dorian M.

AU - Underkoffler, Lara

AU - Segalov, Michelle

AU - Wilson-Rawls, Norma

AU - Cole, Susan E.

AU - Moran, Jennifer L.

AU - Russo, Pierre

AU - Spinner, Nancy B.

AU - Kusumi, Kenro

AU - Loomes, Kathleen M.

PY - 2008

Y1 - 2008

N2 - Alagille syndrome (AGS) is a heterogeneous developmental disorder associated with bile duct paucity and various organ anomalies. The syndrome is caused by mutations in JAG1, which encodes a ligand in the Notch signaling pathway, in the majority of cases and mutations in the NOTCH2 receptor gene in less than 1% of patients. Although a wide array of JAG1 mutations have been identified in the AGS population, these mutational variants have not accounted for the wide phenotypic variability observed in patients with this syndrome. The Fringe genes encode glycosyltransferases, which modify Notch and alter ligand-receptor affinity. In this study, we analyzed double heterozygous mouse models to examine the Fringe genes as potential modifiers of the Notchmediated hepatic phenotype observed in AGS. We generated mice that were haploinsufficient for both Jag1 and one of three paralogous Fringe genes: Lunatic (Lfng), Radical (Rfng), and Manic (Mfng). Adult Jag1+/ - Lfng+/- and Jag1/-Rfng+/ mouse livers exhibited widespread bile duct proliferation beginning at 5 weeks of age and persisting up to 1 year. The Jag1+/-Mfng+/- livers showed a subtle, yet significant increase in bile duct numbers and bile duct to portal tract ratios. These abnormalities were not observed in the newborn period. Despite the portal tract expansion by bile ducts, fibrosis was not increased and epithelial to mesenchymal transition was not shown in the affected portal tracts. Conclusion: Mice heterozygous for mutations in Jag1 and the Fringe genes display striking bile duct proliferation, which is not apparent at birth. These findings suggest that the Fringe genes may regulate postnatal bile duct growth and remodeling, and serve as candidate modifiers of the hepatic phenotype in AGS.

AB - Alagille syndrome (AGS) is a heterogeneous developmental disorder associated with bile duct paucity and various organ anomalies. The syndrome is caused by mutations in JAG1, which encodes a ligand in the Notch signaling pathway, in the majority of cases and mutations in the NOTCH2 receptor gene in less than 1% of patients. Although a wide array of JAG1 mutations have been identified in the AGS population, these mutational variants have not accounted for the wide phenotypic variability observed in patients with this syndrome. The Fringe genes encode glycosyltransferases, which modify Notch and alter ligand-receptor affinity. In this study, we analyzed double heterozygous mouse models to examine the Fringe genes as potential modifiers of the Notchmediated hepatic phenotype observed in AGS. We generated mice that were haploinsufficient for both Jag1 and one of three paralogous Fringe genes: Lunatic (Lfng), Radical (Rfng), and Manic (Mfng). Adult Jag1+/ - Lfng+/- and Jag1/-Rfng+/ mouse livers exhibited widespread bile duct proliferation beginning at 5 weeks of age and persisting up to 1 year. The Jag1+/-Mfng+/- livers showed a subtle, yet significant increase in bile duct numbers and bile duct to portal tract ratios. These abnormalities were not observed in the newborn period. Despite the portal tract expansion by bile ducts, fibrosis was not increased and epithelial to mesenchymal transition was not shown in the affected portal tracts. Conclusion: Mice heterozygous for mutations in Jag1 and the Fringe genes display striking bile duct proliferation, which is not apparent at birth. These findings suggest that the Fringe genes may regulate postnatal bile duct growth and remodeling, and serve as candidate modifiers of the hepatic phenotype in AGS.

UR - http://www.scopus.com/inward/record.url?scp=58149396934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149396934&partnerID=8YFLogxK

U2 - 10.1002/hep.22538

DO - 10.1002/hep.22538

M3 - Article

C2 - 19026002

AN - SCOPUS:58149396934

VL - 48

SP - 1989

EP - 1997

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 6

ER -